gene signatures generally consist of a set of tens to 11 several hundred coding genes, for which a summary 12 metric of their collective expression is associated 13 with a known hallmark, and may help with defining 14 therapeutic strategies [3] . Encapsulated within this 15 methodology and these signatures is a vast amount 16 of biological discovery for particular genes impli-17 cated in the development and progression of these 18 hallmarks. However, since the more recent publica- 19 tion of the updated hallmarks in 2011 [25] , there has 20 been a second revolution in the field of genomics; 21 namely, the discovery of the diverse, critical roles of 22 non-coding RNAs in cancer. 23 Previously thought to be 'junk DNA,' non-24 coding RNA are those RNA derived from DNA 25 that do not code for proteins, and consists of a di- 26 verse family of evolutionarily conserved species, in-27 cluding long non-coding RNA (lncRNA), circular 28 RNA (circRNA), and microRNA (miRNA), among 29 others [23, 40, 41] . Much effort has focused on 30 the characterisation of these non-coding RNA, and 31 early work has shown that these species, particularly 32 miRNA, are involved in a number of cellular de-33 velopmental, and differentiation processes [50] . In 34 addition, miRNA have been implicated in a num-35 ber of human diseases, ranging from diabetes to 36 cancer, and in oncology, recent work has led to 37 the discovery of tumour-suppressive and oncogenic 38 miRNA [7, 42, 44, 49] . miRNA exert their function 39 within the cell primarily as repressors of protein 40 production, functioning as post-transcriptional reg-41 ulators of mRNA, inhibiting translation or encour-42 aging transcript degradation. miRNA exert their 43 effects by complementary base-pair binding to a 44 short 7-8 nucleotide 'seed region' typically located 45 on the 3' untranslated region of the messenger RNA 46 which they inhibit [40] . A single miRNA is thought 47 Our results point towards a scenario wherein the 94 trancriptome of the cancer cell, known to be driven 95 by dysregulation of tumour suppressor genes and 96 oncogenes, is heavily regulated by miRNAs. We 97 show that predicted miRNA-target associations that 98 retain significance across multiple cancer types in-99 volve a number of critical tumour suppressor genes 100 and oncogenes. Study of these tumour suppressor 101 genes yields novel conclusions about their regula-102 tion, particularly with respect to their repression by 103 miRNA, methylation and mutation, and the exclu-104 sivity of the occurrence of these modes of regulation 105 across human cancers.
106

Results
107
Evaluation of Hallmark gene signatures 108 across cancers
109
The first prerequisite to our study was to identify 110 suitable biomarkers to infer cancer phenotype. In or-111 der to achieve this, we chose 24 previously identified 112 gene expression signatures (Supplementary S1) that 113 have already been shown to be representative for a 114 wide number of samples, and a number of fundamen-115 tal phenotypic properties, with the hopes of alleviat-116 ing issues related to highly tissue-specific expression 117 patterns. With this in mind, we applied sigQC, an 118 R package encapsulating a robust methodology for 119 the evaluation of gene signatures on various datasets 120 for the basic statistical properties underlying their 121 applicability [16] . We ran this package on all combi-122 nations of 15 datasets and 24 signatures considered 123 in this study, and tested the consistency of signature 124 performance across cancer types, giving confidence 125 in the application of the signatures to these datasets. 126 All summary plots from the sigQC quality control 127 protocol are presented in Supplementary Section S2. 128 Each of the signatures considered over the 15 epithe-129 lial cancer datasets showed good applicability, strong 130 signature gene expression, moderate-strong compact-131 ness, and good gene signature score variability, as 132 well as strong autocorrelation of signature metrics. 133 The previous validation of these signatures, and our 134 study-specific quality control results, justify our sub-135 sequent use of these signatures in a pan-cancer man-136 ulatory network
141
To determine the association of gene signatures to 142 miRNA expression, we set the signature score (see 3p, -21-5p, -23a-5p, -23a-3p, -24-3p, -24-2-5p, -27a-195 5p, [31] , let-7e-5p, let-7e-3p [11], -22-5p, -22-3p [57] . 196 This analysis also suggests significant, pan-cancer, 197 potential roles for other members of the let-7 family 198 of miRNAs in hypoxia; namely, let-7b-5p, let-7b-3p, 199 let-7d-5p, let-7d-3p, as well as hsa-miR-223-3p, -18a-200 5p, and -28-3p, which have potentially escaped the 201 notice of other approaches.
202
In the context of all gene signatures considered, 203 we identify a global underlying 'map' connecting 204 each miRNA to each gene signature with which we 205 have found an association. As shown in Figure 1d , 206 this is a highly interconnected and complex network, 207 with the conservation of a core set of miRNAs shared 208 across the hallmarks of cancer. A similar analysis re-209 veals an analogous result for the miRNA-hallmarks 210 network for the miRNA negatively associated with 211 both signatures, as described in Supplementary Sec-212 tion S4. To validate the reproducibility of these re-213 sults, we rebuilt the signature-miRNA linear model 214 using a large independent dataset, the Metabric breast 215 cancer cohort [13] . The miRNA identified as posi-216 tively and negatively associated with gene signatures 217 in this dataset show highly significant concordance 218 over a majority of signatures with the correspond-219 ing miRNAs identified from analysis of the TCGA 220 dataset (Supplementary Figure ?? , Section S5). Once the modes of regulation and their relative im-428 portance was established (Figure 3) , we sought to 429 determine the relative occurrence of each of these 430 modes of regulation. We identified which negative 431 regulators co-occurred with each other as synergis-432 tic repressors, and conversely which were exclusive 433 7/22
repressors (Figure 4a) . A cursory analysis of auto-correlation heatmaps (e.g. Figure 4a) -log(p) miRNA cantly up-and down-regulated in association with 530 the signature score. From this, we obtain the net-531 work shown in Figure 1 , which describes for the 532 first time in a detailed fashion, and across cancer 533 types, the contribution of individual miRNA to the 534 complex cancer phenotype. We also show repro-535 ducibility of this network in an independent dataset, 536 by considering the overlap with the network recon-537 structed using the Metabric dataset and the same gene 538 signatures. Moreover, repeating this analysis, group-539 ing the miRNA significantly upregulated and down-540 regulated by miRNA family, illustrates that many 541 miRNA families participate with members antago-542 9/22 
563
As might be expected, given the complexity of 564 the action of non-coding RNA, we show in this 565 work that for a given phenotype, single miRNA- 
611
In this work we further the knowledge of which 612 miRNA are involved in creating the phenotypes 613 of cancer, across tissue types, to identify miRNA-614 TSG targets showing exclusive miRNA-mediated 615 suppression. This suggests that a phenomenon simi-616 lar to that of the previously described 'BRCA-ness,' 617 wherein a miRNA, miR-182, has been shown to 618 repress BRCA and confer sensitivity to PARP in-619 hibitors in a subset of tumours [43] , may be at work 620 within many cases, and across multiple tumour sup-621 pressor genes. Additionally, recent work has shown 622 how 'epimutations' may result in aberrantly methy-623 lated sites that can recapitulate the phenotype of a 624 mutated tumour suppressor such as DNMT3A in 625 leukaemia [27] . This raises the suggestion that there 626 are tumour suppressor genes for which a mutation 627 is not requisite for inactivation, but rather, inactiva-628 tion is achieved through miRNA-mediated repres-629 sion or methylation-mediated repression alone. For 630 the TSG we have identified, we have also shown (see 631 Online Materials), that the TSG mutations are oc-632 curring independently of MYC amplification status, 633 which has been recently identified as an independent 634 regulator of miRNAs. In addition, we show that 635 such MYC amplification status is indeed associated 636 with miRNA expression for the miRNA found to 637 be negatively associated with each of the TSG in 638 a majority of cases (Supplementary Figure ?? , Sec-639 tion S12). Further, we have shown that in partic-640 ular tumours, for PTEN, CDK12, and FAT4, this 641 miRNA or methylation-based suppression happens 642 independently of other gene regulatory factors, such 643 as mutations and copy number changes.
644
Lastly, we show how using generally validated, 645 and specifically quality-controlled, gene signatures 646 describing biologically conserved phenotypes can be 647 used to collate large datasets to derive inference about 648 miRNAs, a species whose signal has been tradition-649 ally hard to detect. The ability of this approach to 650 capture tumour biology is highlighted through the 651 identification of tumour suppressor genes showing 652 miRNA-mediated regulation across tumour types, 653 which we have shown have a very strong association 654 to breast cancer molecular subtype. Specifically, this 655 analysis points towards the role of decreased mRNA 656 levels of ARHGEF12, SFRP4, and TGFBR2 in asso-657 ciation with the poor-prognosis basal breast cancer 658 Table 2 . Counts of common samples with miRNA, mRNA, mutation, methylation, and copy number data. non-silent, non-intronic mutation, and 0 otherwise.
851
The target-miRNA pairs with at least 5 non-zero 852 entries across cancer types were kept for further anal-853 ysis, and subsequently were analysed using the rank 854 product statistic, to identify those pairs with con-855 sistently negative correlations, across cancer types, 856 with respect to all other hallmarks-miRNA pairs. 857 Partial correlations were done in R using the ppcor 858 package [30] .
859
Furthermore, in the global analysis of all TSG-860 miRNA pairs, we considered every TSG-miRNA 861 predicted target pair, and again considered the Spear-862 man correlation partial to mutation status, collaps-863 ing the value to 0 if significance p < 0.05. The rank 864 product statistic was again considered on those pairs 865 
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with at least 5 non-zero values across cancer types, thereby identifying those TSG-miRNA pairs con- To determine the exclusivity of gene regulation, we 911 calculated the empiric distributions of the variables 912 Π ρ k as defined graphically in Figure 4 . These repre-913 sent the proportion of miRNA-miRNA or miRNA-914 methylation or methylation probe-methylation 915 probe pairs that show significant positive Spear-916 man co-correlation (p < 0.05). For the bootstrap-917 ping analysis, we resampled the datasets, choosing 918 miRNA and methylation probes in the same num-919 ber as the heatmap in question, and then considered 920 the distributions of the pairwise differences in the 921 variables Π ρ k . From these distributions for the pair-922 wise differences, we were able to infer the percentile 923 on the empirically constructed CDF that the true 924 case represented, the results of which are depicted in 925 Figure 4b , showing, for each gene and cancer type, 926 the percentile on the pairwise difference empiric 927 distribution for the observed heatmap.
928
The calculations for the analysis of TSG regula-929 tion and analysis for the exclusivity of gene regula-930 tion were repeated for an idependent dataset com-931 prising matched mRNA, miRNA, CNV, mutation, 932 and methylation data for 93 patients with ovarian 933 cancer, from the OV-AU project from the ICGC data 934 portal [58] . Results of this analysis are highlighted 935 in Supplementary Section S9, Figure ? ?. 
